NEW YORK, June 16, 2016 /PRNewswire/ — The growing awareness about the importance of child healthcare and well-being is driving the market for pediatric vaccines globally. Pediatric vaccine continues to be one of the booming segment for the pharmaceutical companies. Pediatric vaccines are used in the prevention of numerous diseases, such as Hepatitis- A and -B. Measles, Influenza, Polio, Tetanus, and Diphtheria. Increasing government and non-government funding for development of vaccine is the major driver for the pediatric vaccine market. The rising incidence of diseases such as influenza, hepatitis and HPV has also fueled the demand for the global pediatric vaccines market. The vaccines industry also faces hindrances such as vaccine safety, shortages and delays, vaccine development time line as well as entry barriers for new manufacturers.
Pediatric Vaccines Market – Disease Wise Analysis
The pneumococcal vaccines accounts for maximum share of the pediatric vaccines market. The DTaP vaccines were the second most popular segment in the year 2015. It is competing closely with MMRV vaccines which controlled XX% share of the pediatric vaccines market in 2015. The rotavirus and influenza vaccines stands at fourth and fifth spots respectively in 2015. While vaccines for Polio, meningococcal and HPV are also gaining ground in pediatric vaccines market landscape.
Pediatric Vaccines Market – Company Analysis
Pediatric Vaccines Market – Disease Wise Company Sales Analysis
Global Pediatric Vaccines Market – Disease Wise Analysis to 2021 (10 Disease Analysed)